NCT00677924View on ClinicalTrials.gov

Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Colorectal Cancer
Interventions
DRUG

Zalutumumab

Solution for infusion

Trial Locations (3)

1000

Institut Jules Bordet, Brussels

1070

Hospital Erasme, Brussels

1200

St-Luc University Hospital, Brussels

Sponsors

Lead Sponsor

Genmab
All Listed Sponsors
lead

Genmab

INDUSTRY

NCT00677924 - Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer | Biotech Hunter | Biotech Hunter